We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 10.00 | 0.61% | 1,646.00 | 1,645.50 | 1,646.00 | 1,656.00 | 1,635.00 | 1,642.00 | 1,874,713 | 13:54:49 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.78 | 67.89B |
From Apr 2019 to Apr 2024
TIDMGSK
RNS Number : 7979U
GlaxoSmithKline PLC
20 October 2014
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of the following increases in interests in Ordinary Shares in GlaxoSmithKline plc purchased at a price of 1411.09 pence per Share on 3 October 2014, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 2 October 2014.
Hot Features
Premium
Ordinary Shares
------------------- ------------------
Sir Andrew Witty 1434.057
------------------- ------------------
Mr R G Connor 91.016
------------------- ------------------
Mr S Dingemans 662.544
------------------- ------------------
Mr S A Hussain 1818.946
------------------- ------------------
Mr D S Redfern 666.527
------------------- ------------------
Dr M M Slaoui 148.779
------------------- ------------------
Ms C Thomas 812.376
------------------- ------------------
Mr P C Thomson 262.941
------------------- ------------------
Dr P J T Vallance 917.784
------------------- ------------------
Ms E Walmsley 744.535
------------------- ------------------
The Company was advised of this information on 17 October 2014.
This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
20 October 2014
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSEBLFLZBFFFBF
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
